drugset / Trial / NCT07248384

The Efface of Ketamine vs. Lidocaine in the Management of Pain After Laparoscopic Cholecystectomy

NCT07248384

Phase 1 Completed 76 enrolled Liaquat National Hospital & Medical College
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This prospective interventional study conducted at Liaquat National Hospital and Medical College compared the analgesic efficacy of ketamine and lidocaine in managing postoperative pain after laparoscopic cholecystectomy. Total of 76 ASA I-II patients were randomly assigned into two equal groups (Group K: Ketamine, Group L: Lidocaine) using a sealed-envelope method in a double-blind, placebo-controlled design. Standard anesthesia with propofol, isoflurane, and atracurium was administered, and all patients received postoperative diclofenac sodium and ondansetron. Pain intensity was assessed using the Visual Analogue Scale (VAS) at 1, 6, 12, and 24 hours postoperatively. The study aimed to compare the pain-relieving effects of ketamine and lidocaine, contributing to improved strategies for postoperative pain management following laparoscopic cholecystectomy.

Timeline

Start
2023-07-15
Primary completion
2025-08-20
Completion
2025-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.5 mg/kg Intravenous
Comparator Lidocaine Other / unclassified 60 mg/kg Intravenous

Indications